An Innovative Strategy for the Effective Reduction of MDR Pathogens from the Nosocomial Environment.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2019
Historique:
pubmed: 20 7 2019
medline: 18 12 2019
entrez: 20 7 2019
Statut: ppublish

Résumé

Antimicrobial resistance (AMR) is currently one of the main concerns for human health.Due to its rapid increase and global diffusion, several common microbial infections might become not curable in the future decades, making it impossible to apply other lifesaver therapies, such as transplant or chemotherapy.AMR is frequently observed in hospital pathogens, due to selective pressure exerted by antibiotic use, and consistently with this, in the recent years, many actions have been proposed to limit AMR spread, including hygiene measures for hospital professionals and a wiser antibiotic usage.Indeed, the hospital environment itself represents a reservoir of pathogens, whose control was so far addressed by conventional sanitation procedures, which however cannot prevent recontamination and might further favour the selection of resistant strains.Here we report the results collected by studying an innovative sanitation strategy based on the use of probiotic bacteria, capable of reducing in a stable way the surface load of pathogens and their AMR. Collected data suggest that this system might contribute significantly to AMR control and might be thus considered as one of the tools for AMR and infection prevention and control.

Identifiants

pubmed: 31321750
doi: 10.1007/5584_2019_399
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-91

Auteurs

Elisabetta Caselli (E)

Section of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. csb@unife.it.
CIAS Research Center, University of Ferrara, Ferrara, Italy. csb@unife.it.

Maria D'Accolti (M)

Section of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
CIAS Research Center, University of Ferrara, Ferrara, Italy.

Irene Soffritti (I)

Section of Microbiology and Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
CIAS Research Center, University of Ferrara, Ferrara, Italy.

Luca Lanzoni (L)

CIAS Research Center, University of Ferrara, Ferrara, Italy.

Matteo Bisi (M)

CIAS Research Center, University of Ferrara, Ferrara, Italy.

Antonella Volta (A)

CIAS Research Center, University of Ferrara, Ferrara, Italy.

Filippo Berloco (F)

Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.

Sante Mazzacane (S)

CIAS Research Center, University of Ferrara, Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH